Registration requirements for importers and manufacturers of prescription drug products containing ephedrine, pseudoephedrine, or phenylpropanolamine. Final rule.
The Drug Enforcement Administration (DEA) is amending its registration regulations to ensure that a registration is obtained for every location where ephedrine, pseudoephedrine, or phenylpropanolamine, or drug products containing one of these chemicals, are imported or manufactured. These amendments will make it possible to establish the system of quotas and assessment of annual needs for the importation and manufacture of these chemicals that Congress mandated in the Combat Methamphetamine Epidemic Act of 2005.
D000662:Amphetamines; D003132:Commerce / Q000331:legislation & jurisprudence*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D004809:Ephedrine; D006801:Humans; D007880:Legislation, Drug; D010665:Phenylpropanolamine; D055553:Prescription Drugs; D054199:Pseudoephedrine; D012042:Registries; D014481:United States
D000662:Amphetamines; D055553:Prescription Drugs; D010665:Phenylpropanolamine; D054199:Pseudoephedrine; D004809:Ephedrine